SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaera Corp
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave Mordis who wrote (65)10/6/2005 12:25:16 PM
From: DewDiligence_on_SI  Read Replies (1) of 96
 
Does fast track speed up the process any?

Only to the extent that it makes a six-month Priority Review (rather than the standard 10-month review) more likely than without Fast Track. In other words, fast Track is a relatively minor issue in the overall timeline.

A much bigger timeline issue is how fast the phase-3 trials will enroll patients. Regards, Dew
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News